Review
Accepted on 06 Mar 2025
Exercise and Diet Studies Among Patients Living with Multiple Myeloma: Current Evidence and Considerations of Patient Preferences
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1550681
Type at least 3 characters
122 articles
Articles
Case Report
Published on 04 Mar 2025
Case Report: Triplet combination with pirtobrutinib/venetoclax/rituximab in accelerated phase of chronic lymphocytic leukemia
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1552200
- 358 views
Editorial
Published on 04 Mar 2025
Editorial: Hematopoietic stress in stem cell homeostasis and disease pathogenesis
in Hematopoiesis and Stem Cells
Frontiers in Hematology
doi 10.3389/frhem.2025.1571674
- 225 views
Review
Published on 03 Mar 2025
Abnormalities of primary and secondary hemostasis in multiple myeloma: insights from studies on thrombopoiesis, the coagulation system, and the bone marrow microenvironment
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1435193
- 462 views
Original Research
Published on 27 Feb 2025
FACIT-Fatigue scale in patients with cold agglutinin disease: psychometric validation and estimation of clinically meaningful change
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1490130
- 172 views
Mini Review
Published on 26 Feb 2025
The role of glucocorticoids in erythropoiesis
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1540152
- 251 views
Case Report
Published on 26 Feb 2025
Acquired von Willebrand disease associated with smoldering multiple myeloma and hereditary hemorrhagic telangiectasia successfully treated with daratumumab, pomalidomide, and dexamethasone: hitting three birds with one stone? – case report
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1499500
- 285 views
Original Research
Accepted on 24 Feb 2025
Cochrane's Contribution to Global Health: Three Decades of Progress in Sickle Cell Disease Research
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1535100
Original Research
Published on 21 Feb 2025
Time to initiation of antiresorptive agents in multiple myeloma to reduce skeletal related events
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1521017
- 213 views
Original Research
Accepted on 14 Feb 2025
HPLC first approach in detecting thalassemia and other common hemoglobinopathies is more cost and time effective
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1461498
- 212 views
Mini Review
Published on 07 Feb 2025
The aging hematopoietic stem cell niche: a mini review
in Hematopoiesis and Stem Cells
Frontiers in Hematology
doi 10.3389/frhem.2025.1525132
- 401 views
Editorial
Published on 24 Jan 2025
Editorial: Two decades of targeted therapies in hematology: new targets and novel combinations
in Immunobiology and Immunotherapy
Frontiers in Hematology
doi 10.3389/frhem.2025.1548984
- 374 views
Original Research
Published on 21 Jan 2025
Impact of leukemia subtype and demographics on patient quality of life in 76 countries: a cross-sectional study
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1502166
- 1,524 views
Case Report
Published on 16 Jan 2025
Case report: VEXAS syndrome: first documented cases in Latin America
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1501337
- 253 views
Case Report
Published on 10 Jan 2025
Case report: A decade-long journey with cyclic thrombocytopenia
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1482891
- 274 views
Original Research
Published on 26 Dec 2024
Unique target binding by the C-terminal region of FHR1 provides a new perception of aHUS pathology
in Immunobiology and Immunotherapy
Frontiers in Hematology
doi 10.3389/frhem.2024.1469176
- 584 views